Cosmo Pharmaceuticals N.V.

Cosmo Pharmaceuticals N.V.verified

CMOPF

Price:

$112.5

Market Cap:

$1.53B

Cosmo Pharmaceuticals N.V., a specialty pharmaceutical company, focuses on the development and commercialization products for gastroenterology and endoscopy worldwide. It offers Lialda/Mezavant/Mesavancol and UCERIS/Cortiment, an oral tablet formulation for remission in active, mild to moderate ulcerative colitis; GI Genius, a system that uses artificial intelligence to detect colorectal polyps; and Methylene Blue MMX, diagnostic drug to enhance pre-cancerous and cancerous detection of colorectal lesions during colonoscopy. The company also provides Eleview, an injectable composition for use in gastrointestinal endoscopic procedures for submucosal lift of polyps, adenomas, early-stage cancer...[Read more]

Industry

Drug Manufacturers - General

IPO Date

2017-07-31

Stock Exchange

OTC

Ticker

CMOPF

The Enterprise Value as of December 2025 (TTM) for Cosmo Pharmaceuticals N.V. (CMOPF) is 1.48B

According to Cosmo Pharmaceuticals N.V.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.48B. This represents a change of 50.24% compared to the average of 988.08M of the last 4 quarters.

Cosmo Pharmaceuticals N.V. (CMOPF) Historical Enterprise Value (quarterly & annually)

How has CMOPF Enterprise Value performed in the past?

The mean historical Enterprise Value of Cosmo Pharmaceuticals N.V. over the last ten years is 1.32B. The current 1.48B Enterprise Value has changed 11.18% with respect to the historical average. Over the past ten years (40 quarters), CMOPF's Enterprise Value was at its highest in in the December 2015 quarter at 2.79B. The Enterprise Value was at its lowest in in the June 2009 quarter at 0.

Quarterly (TTM)
Annual

Average

1.32B

Median

1.10B

Minimum

834.11M

Maximum

2.11B

Cosmo Pharmaceuticals N.V. (CMOPF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Cosmo Pharmaceuticals N.V. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 27.84%

Maximum Annual Enterprise Value = 2.11B

Minimum Annual Increase = -32.81%

Minimum Annual Enterprise Value = 834.11M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20241.07B27.84%
2023834.11M-16.84%
20221.00B-3.18%
20211.04B-7.48%
20201.12B2.92%
20191.09B-5.35%
20181.15B-32.81%
20171.71B-19.07%
20162.11B3.77%
20152.04B18.09%

Cosmo Pharmaceuticals N.V. (CMOPF) Average Enterprise Value

How has CMOPF Enterprise Value performed in the past?

The current Enterprise Value of Cosmo Pharmaceuticals N.V. (CMOPF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

967.80M

5-year avg

1.01B

10-year avg

1.32B

Cosmo Pharmaceuticals N.V. (CMOPF) Enterprise Value vs. Peers

How is CMOPF’s Enterprise Value compared to its peers?

Cosmo Pharmaceuticals N.V.’s Enterprise Value is less than Sawai Group Holdings Co., Ltd. (325.14B), less than Kissei Pharmaceutical Co., Ltd. (158.58B), less than Trulieve Cannabis Corp. (1.49B), less than Towa Pharmaceutical Co., Ltd. (367.30B), less than Raffles Medical Group Ltd (1.56B), less than Nippon Shinyaku Co., Ltd. (282.70B), less than SSY Group Limited (11.84B), greater than Evotec SE (1.19B), less than China Traditional Chinese Medicine Holdings Co. Limited (9.85B), greater than Genetic Technologies Limited (5.53M),

Build a custom stock screener for Cosmo Pharmaceuticals N.V. (CMOPF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cosmo Pharmaceuticals N.V. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cosmo Pharmaceuticals N.V. (CMOPF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cosmo Pharmaceuticals N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Cosmo Pharmaceuticals N.V.'s Enterprise Value?

What is the highest Enterprise Value for Cosmo Pharmaceuticals N.V. (CMOPF)?

What is the 3-year average Enterprise Value for Cosmo Pharmaceuticals N.V. (CMOPF)?

What is the 5-year average Enterprise Value for Cosmo Pharmaceuticals N.V. (CMOPF)?

How does the current Enterprise Value for Cosmo Pharmaceuticals N.V. (CMOPF) compare to its historical average?